Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1999

Conditions
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant interferon gamma

Trial Locations (1)

14642

University of Rochester Cancer Center, Rochester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester

OTHER